Hair loss treatments do not all work in the same way. The most suitable option depends on the cause of your hair loss, your medical history and the balance between potential benefits and side effects.
Understanding the main approaches can help you have a more informed conversation with your clinician.
Topical Minoxidil: supporting hair growth
Minoxidil helps support hair growth and can improve hair density in some people with pattern hair loss. It does not block DHT. Minoxidil helps hair follicles enter and remain in the growth phase for longer, which can improve hair thickness and coverage.
Topical minoxidil is applied to the scalp as a solution or foam. Certain products are licensed for male or female pattern hair loss, with instructions that vary by product.
Possible side effects include scalp dryness, irritation and unwanted hair growth outside the treatment area. Temporary increased shedding can also occur when treatment begins.
What about oral minoxidil?
Clinicians sometimes prescribe oral minoxidil for hair loss. This is an off-label use, meaning that the medicine is being used outside its UK licence.
Oral treatment affects the whole body and needs an individual assessment and appropriate monitoring. Possible side effects include increased facial or body hair, dizziness, ankle swelling and palpitations.
DHT blockers: addressing a hormonal contributor
Finasteride and dutasteride reduce the conversion of testosterone into dihydrotestosterone (DHT), a hormone that contributes to follicle shrinkage in male pattern hair loss. Lowering DHT can help slow further thinning and preserve existing hair.
Reducing DHT can help slow further hair loss and allow some miniaturised follicles to produce thicker hairs. Results vary, and continued treatment is generally needed to maintain benefits.
Finasteride and dutasteride block 5-alpha reductase, the enzyme that converts testosterone into DHT:
Medicine
How it works
Finasteride
Mainly blocks type 2 of the enzyme, reducing DHT levels.
Dutasteride
Blocks types 1 and 2, producing greater DHT suppression.
Reducing DHT can help slow further hair loss and allow some miniaturised follicles to produce thicker hairs. Results vary, and continued treatment is generally needed to maintain benefits.
Topical DHT blockers: a targeted approach
Applied directly to the scalp, topical DHT blockers offer an alternative to oral treatment. Topical formulations have shown improved hair growth with lower bloodstream exposure and less reduction in circulating DHT.
Topical treatment can still be absorbed into the body; it should not be assumed to be free from systemic side effects. Some patients can experience scalp irritation and suitability depends on the specific formulation, dose and your medical history.
Oral DHT blockers
Oral Finasteride is licensed for male pattern hair loss in suitable men. Dutasteride use for hair loss is off-label. These medicines are not appropriate for everyone and must not be used during pregnancy.
Potential risks can include sexual side effects. Finasteride also carries warnings about depression and suicidal thoughts, and sexual symptoms have sometimes persisted after stopping treatment. Dutasteride carries precautionary advice about mood changes.

Why might treatments be combined?
A clinician may consider treatments with different mechanisms together—for example, supporting growth while reducing the effects of DHT. However, using more ingredients does not automatically mean better results.
Why might treatments be combined?
Hair loss treatments work in different ways, so a clinician may recommend combining them to address more than one aspect of male or female pattern hair loss.
For example, minoxidil helps hair follicles enter and remain in the growth phase, while DHT-blocking medicines reduce a hormonal contributor to follicle shrinkage. Used together in suitable patients, these approaches may help preserve existing hair while encouraging thicker growth.
A treatment plan might involve separate products or, where clinically appropriate, a combined formulation. A single preparation can simplify the routine, although separate products allow each medicine to be adjusted independently.
Bespoke formulations can be unlicensed and will be considered on an individual clinical need basis. Your clinician will consider your hair loss pattern, medical history, previous response and preferences before recommending a combination, with follow-up to assess its benefits and tolerability.
Speak to Pharmacy Cube
Speak to the Pharmacy Cube team to explore your treatment options and discuss whether a bespoke formulation could be suitable for you.
Contact Pharmacy Cube on 0203 662 0722 or email info@pharmacycube.co.uk.
This article provides general information and does not replace an individual clinical assessment. Treatment and supply are subject to suitability, prescription requirements and availability.
Registered with the General Pharmaceutical Council
GPhC Registration No: 9012289
Registered Owner: Cube Therapies Ltd
Superintendent Pharmacist: Mr Nasir Khan
.png)
